on the synthesis, cytotoxicity, and DNA binding of netropsin-
proximicin-hybrids combining the N-methyl pyrrol amino
acid of netropsin with N- and C-terminal residues derived
from the proximicins.4 In this contribution, we present the
first total synthesis of the proximicins (3-5) and examine
the influence of structural modifications of analogues (6-12)
with a furan amino acid core on DNA-binding.
A considerable number of syntheses toward variously
substituted furans have been reported to date, assembled
either by condensation and metal-catalyzed cyclization of
linear precursors or by directly performing substitutions at
the furan ring. However, methods for preparation of 2,4-
disubstituted furans are rare.5 Our attempts were directed at
a three step synthesis of the central core amino acid of the
proximicins beginning with commercially available 3-fural-
dehyde (13), which was selectively lithiated at the C-5
position (Scheme 1).6 Subsequent trapping of the lithiated
Scheme 1
.
Total Synthesis of Proximicin A (3), B (4), and C
(5)
Figure 1. Structures of netropsin (1), distamycin (2), proximicin
A-C (3-5), and of newly designed potential minor groove binders
(6-12). Structures of compounds capable to act as DNA-binding
agents are marked with a green check.
Recently, proximicin A, B, and C (3-5) composed of a
dipeptide of a 2,4-disubstituted furan amino acid were
isolated from a marine actinomycete of the genus Verruco-
sispora (Figure 1).3 Besides the apparent structural similari-
ties of the proximicin core to netropsin (1) and distamycin
(2) the central dipeptide of 4-amino-furan-2-carboxylic acids
has neither been reported for natural products nor from
synthetic studies. In proximicins the charged residues of (1)
and (2) are formally replaced by an N-terminal methyl
carbamate and C-terminal amides, respectively. These struc-
tural differences of proximicins apparently lead to a change
of the molecular target.3a Remarkably, it was found through
cell cycle analysis and the expression level of cell cycle
regulating proteins (p53, p21, and cyclinE) that, in contrast
to distamycin (2), the proximicins address the G0/G1 phase
of the cell cycle.3a Previous experimental work has reported
species with methyl chloroformate led to derivative 14. The
aldehyde 14 was oxidized under mild conditions to the
corresponding carboxylic acid (15) which was further
converted by a Curtius rearrangement to the central 2,4-
disubstituted furan amino acid in a suitably protected form
(16) in good yields. Removal of the Boc-group and introduc-
tion of the methyl carbamate functionality led to 18. The
methyl ester was easily saponified and the resulting free acid
was coupled without further purification to previously
synthesized H-Fu-OMe•HCl (17) with HOAt/EDCI to yield
Meoc-Fu-Fu-OMe (19) After saponification of dipeptide 19
(2) (a) Bailly, C.; Chaires, J. B. Bioconjug. Chem. 1998, 9, 513–538.
(b) Dervan, P. B.; Poulin-Kerstien, A. T.; Fechter, E. J.; Edelson, B. S.
Top. Curr. Chem. 2005, 253, 1–31. (c) Lown, J. W. J. Mol. Recognit. 1994,
7, 79–88. (d) Wemmer, D. E. Annu. ReV. Biophys. Biomol. Struct. 2000,
29, 439–461. (e) Dervan, P. B. Bioorg. Med. Chem. 2001, 9, 2215–2235.
(f) Boger, D. L.; Fink, B. E.; Hedrick, M. P. J. Am. Chem. Soc. 2000, 122,
6382–6394. Incorporation of a 2,5-disubstituted furan amino acid: (g) Lee,
M.; Krowicki, K.; Shea, R. G.; Lown, J. W.; Pon, R. T. J. Mol. Recogn.
1989, 2, 84–93.
(4) Wolter, F. E.; Molinari, L.; Socher, E. R.; Schneider, K.; Nicholson,
G.; Beil, W.; Seitz, O.; Su¨ssmuth, R. D. Bioorg. Med. Chem. Lett. 2009,
doi: 10.1016/j.bmcl.2009.04.042.
(5) (a) Lee, H. K.; Chan, K. F.; Hui, C. W.; Yim, H. K.; Wu, X. W.;
Wong, H. N. C. Pure Appl. Chem. 2005, 77, 139–143. (b) Kirsch, S. F.
Org. Biomol. Chem. 2006, 4, 2076–2080. (c) Keay, B. A. Chem. Soc. ReV.
1999, 28, 209–215. (d) Jeevanandam, A.; Ghule, A.; Ling, Y. C. Curr.
Org. Chem. 2002, 6, 841–864. (e) Hou, X. L.; Cheung, H. Y.; Hon, T. Y.;
Kwan, P. L.; Lo, T. H.; Tong, S. Y.; Wong, H. N. C. Tetrahedron 1998,
54, 1955–2020. (f) Gilchrist, T. L. J. Chem. Soc., Perkin Trans. 1 1999,
2849–2866. (g) Brown, R. C. D. Angew. Chem., Int. Ed. 2005, 44, 850–
852.
(3) (a) Schneider, K.; Keller, S.; Wolter, F. E.; Roeglin, L.; Beil, W.;
Seitz, O.; Nicholson, G.; Bruntner, C.; Riedlinger, J.; Fiedler, H.-P.;
Su¨ssmuth, R. D. Angew. Chem., Int. Ed. 2008, 47, 3258–3261. (b) Fiedler,
H.-P.; Bruntner, C.; Riedlinger, J.; Bull, A. T.; Knutsen, G.; Goodfellow,
M.; Jones, A.; Maldonado, L.; Pathom-Aree, W.; Beil, W.; Schneider, K.;
Keller, S.; Su¨ssmuth, R. D. J. Antibiot. 2008, 61, 158–163.
(6) Lee, G. C. M.; Holmes, J. M.; Harcourt, D. A.; Garst, M. E. J. Org.
Chem. 1992, 57, 3126–3131.
Org. Lett., Vol. 11, No. 13, 2009
2805